Accessibility Menu
 
Novozymes A/s logo

Novozymes A/s

(OTC) NVZMY

Current Price$54.11
Market Cap$22.30B
Since IPO (2003)+1,468%
5 Year-8%
1 Year-8%
1 Month-11%

Novozymes A/s Financials at a Glance

Market Cap

$22.30B

Revenue (TTM)

$11.01B

Net Income (TTM)

$1.47B

EPS (TTM)

$1.40

P/E Ratio

38.49

Dividend

$0.96

Beta (Volatility)

0.50 (Low)

Price

$54.11

Volume

92,823

Open

$54.53

Previous Close

$54.11

Daily Range

$52.76 - $54.66

52-Week Range

$49.90 - $75.99

NVZMY News

No articles available.

NVZMY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novozymes A/s

Industry

Chemicals

Sector

Materials

Employees

11,641

CEO

Ester Baiget, MBA

Headquarters

Bagsvaerd, 2880, DK

NVZMY Financials

Key Financial Metrics (TTM)

Gross Margin

54%

Operating Margin

5%

Net Income Margin

8%

Return on Equity

5%

Return on Capital

6%

Return on Assets

9%

Earnings Yield

2.60%

Dividend Yield

0.02%

Payout Ratio

27.27%

Stock Overview

Market Cap

$22.30B

Shares Outstanding

412.17M

Volume

92.82K

Short Interest

0.00%

Avg. Volume

94.77K

Financials (TTM)

Gross Profit

$2.24B

Operating Income

$882.60M

EBITDA

$1.39B

Operating Cash Flow

$1.22B

Capital Expenditure

$470.80M

Free Cash Flow

$750.70M

Cash & ST Invst.

$295.60M

Total Debt

$22.45B

Novozymes A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$996.60M

-86.6%

Gross Profit

$2.94B

-382.3%

Gross Margin

-2.95%

N/A

Market Cap

$22.30B

N/A

Market Cap/Employee

$2.11M

N/A

Employees

10,582

N/A

Net Income

$122.80M

-49.2%

EBITDA

$2.02B

+364.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$22.15B

-1364.2%

Accounts Receivable

$869.40M

+8.1%

Inventory

$772.20M

+7.2%

Long Term Debt

$9.74B

+536.3%

Short Term Debt

$12.71B

+4670.1%

Return on Assets

9.03%

N/A

Return on Invested Capital

6.49%

N/A

Free Cash Flow

$101.50M

-63.7%

Operating Cash Flow

$328.20M

-33.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SKFOFSika AG
$157.96-7.76%
SXYAYSika AG
$15.85-5.65%
SLMNPA. Schulman, Inc.
$870.00+0.12%
EMSHFEms-Chemie Holding AG
$794.49-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$172.70-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%

Questions About NVZMY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.